Compare ARK Genomic Revolution ETF (ARKG) vs YieldMax MSTR Option Income Strategy ETF (MSTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs YieldMax MSTR Option Income Strategy ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.89, while YieldMax MSTR Option Income Strategy ETF trades at $12.46. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, YieldMax MSTR Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | MSTY | |
|---|---|---|
Sector | Sector/Thematic | Income / Options Overlay |
52-Week High | $43.57 | $114.30 |
52-Week Low | $23.09 | $11.55 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
MSTY trades at $12.83, up 0.79% today, but technical indicators signal a bearish trend with moving averages and ADX pointing lower. The ETF maintains a high distribution schedule, paying weekly dividends, though recent news highlights concerns over uncapped losses and NAV erosion. Support is clustered around $12-$13, with resistance just above the current price.
Outlook remains cautious due to structural risks from the covered-call strategy capping upside. High yield appeals to income seekers, but total return depends on preserving capital. Key risks include Strategy stock volatility and return-of-capital distributions undermining long-term value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About YieldMax MSTR Option Income Strategy ETF
MSTY is an actively managed ETF that pursues a synthetic covered call strategy on MicroStrategy Incorporated (MSTR) stock. The fund primarily sells call options on MSTR and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the volatile, Bitcoin-correlated growth potential of MSTR while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on MSTY →
